• Login
• Home
• About
• Current
• Archives
• Search
• Submissions
• Board
• SEEd

Home > Archives > Vol 4, No 5S (2010)

Table of Contents

Editorial

Let's have a look at suboptimal patients in TKI era Antonella Gozzini

PDF 3-7

Case report

Treatment with nilotinib after cytogenetic relapse at 12 months in a patient in chronic phase with sub-optimal response to imatinib Massimo Breccia

PDF 9-13

Nilotinib efficacy in a patient resistant to imatinib Luigia Luciano

PDF 15-18

Use of nilotinib in the diabetic patient Carmen Tomaselli

PDF 19-22

Nilotinib therapy after resistance and intolerance to imatinib in CML patient with trisomy of the chromosome 8 Antonella Russo Rossi

PDF 23-27